Times, they've been a-changin' for disease-modifying therapies. When I was diagnosed with multiple sclerosis in 1980, there were no DMTs. The first, the injectable Betaseron (interferon beta-1b), was approved by the U.S. Food and Drug Administration in 1993 for relapsing-remitting MS. A few years later, I was thrilled to be included in the Phase 3 […]
Read more of this post
No comments:
Post a Comment